Skip to main content
Eisai Co., Ltd. logo

Eisai Co., Ltd. — Investor Relations & Filings

Ticker · 4523 ISIN · JP3160400002 LEI · 353800HDEE0ZYEX4QV91 T Manufacturing
Open in API
Filings indexed 75 across all filing types
Latest filing 2022-06-17 Governance Information
Country JP Japan
Listing T 4523

About Eisai Co., Ltd.

https://www.eisai.com/index.html

Eisai Co., Ltd. is a research-based global pharmaceutical company engaged in the discovery, development, manufacture, and marketing of prescription medicines. The company's primary business activities are concentrated in the therapeutic areas of neurology, with a significant focus on dementia-related diseases, and oncology. Guided by its core "human health care" (hhc) philosophy, Eisai prioritizes the needs of patients and their families. The company is dedicated to developing innovative and targeted treatments for challenging medical conditions and actively promotes initiatives to improve access to medicines in developing and emerging countries.

Recent filings

Filing Released Lang Actions
内部統制報告書－第110期(令和3年4月1日－令和4年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. This type of document is a specific regulatory requirement in Japan, often filed alongside or as part of the annual reporting cycle, but it functions as a standalone audit-related disclosure regarding internal control effectiveness. Given the provided categories, 'AR' (Audit Report / Information) is the most appropriate classification as it covers internal control assessments and audit-related regulatory disclosures.
2022-06-17 Japanese
有価証券報告書－第110期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains the standard cover page for such filings, including the company name (Eisai Co., Ltd.), the fiscal year (110th term, 2021-04-01 to 2022-03-31), and the submission date (2022-06-17). It is a comprehensive annual financial report filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. FY 2022
2022-06-17 Japanese
四半期報告書－第110期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Eisai Co., Ltd. for the third quarter of the 110th fiscal period (ending December 31, 2021). It contains detailed financial statements, management analysis (MDA), and segment performance data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-02-14 Japanese
四半期報告書－第110期第2四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Eisai Co., Ltd. with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MDA), and segment performance for the second quarter of the 110th fiscal period (April 1, 2021, to September 30, 2021). As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. Q2 2021
2021-11-09 Japanese
四半期報告書－第110期第1四半期(令和3年4月1日－令和3年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Eisai Co., Ltd., covering the first quarter of the 110th fiscal period (April 1, 2021, to June 30, 2021). It contains detailed financial statements, management analysis of financial conditions, and operational results, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-08-06 Japanese
内部統制報告書－第109期(令和2年4月1日－令和3年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法) in Japan. This type of report details the company's framework, scope, and evaluation of internal controls over financial reporting. Since it is a formal regulatory filing regarding internal control systems and does not fit into specific categories like 10-K, ER, or AGM-R, it falls under the 'Regulatory Filings' category.
2021-06-18 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.